This notice concerns all customers of Les Entreprises Médicales de l’Outaouais as well as consumers of certain Phillips Respironics brand sleep and respiratory treatment devices.

The Philips company has issued an updated recall notice for their sleep apnea products, commonly known as “CPAP machines.” The brand has issued a voluntary recall notice for its devices following risks of deterioration and emissions of volatile organic compounds from the noise-canceling foam.

The Philips company recommends that you stop using your device and consult your doctor or Les Entreprises medical de l’Outaouais to determine the most appropriate solution for the rest of your treatment.

“We deeply regret any concerns or inconvenience suffered by users of the affected devices generated by the proactive measures we are announcing today to ensure patient safety,” said Frans van Houten, CEO of Royal Philips.

“In consultation with the relevant regulators and working closely with our customers and partners, we are doing everything we can to find a solution. This includes the dissemination of updated operating instructions and a comprehensive repair and replacement program for affected devices. Patient safety is at the heart of everything we do at Philips. ”

Specifically, the recall affects Philips brand two-level positive airway pressure (two-level PAP), continuous positive airway pressure (CPAP) and mechanical ventilation devices to respond to the potential health risks associated with it. to one of the components of these devices, namely the polyurethane sound insulation foam based on polyester.

Risks include the degradation of the PE-PUR foam into particles which can enter the air path of the device and be ingested or inhaled by the user, and the release of certain chemicals in the form of gases by the foam. . Degradation of the foam can be caused by improper cleaning of the appliance, for example with ozone-based products. Very hot and humid environments can also contribute.